Medical malpractice implications of PSA testing for early detection of prostate cancer.
Medical malpractice implications of PSA testing for early detection of prostate cancer.
复制标题
PSA 检测对前列腺癌早期检测的医疗事故影响。
DOI：
10.1111/j.1748-720x.1997.tb01405.x
复制
发表时间：
1997
期刊：
影响因子：
--
通讯作者：
Barry,MJ
中科院分区：
文献类型：
--
作者：
Collins,MM;FowlerJr,FJ;Roberts,RG;Oesterling,JE;Annas,GJ;Barry,MJ
前列腺癌已经成为美国男性的主要健康问题。它现在是最常见的非皮肤病癌症，也是男性癌症死亡的第二大原因。近年来，前列腺癌的发病率迅速上升，部分原因是前列腺特异性抗原（PSA）检测;直到现在才逐渐减少。PSA筛查前列腺癌在美国很普遍，但存在争议：美国泌尿外科协会建议PSA筛查，美国癌症协会建议提供筛查;然而，美国预防服务工作组（USPSTF）和美国医师学院（ACP）建议反对常规筛查;美国家庭医生学会认为，筛查的决定应该留给病人。
Prostate cancer has become a major health concern of male Americans. It is now the most common nondermatologic cancer and the second leading cause of cancer death among men. The incidence of detected prostate cancer rose rapidly in recent years, partly because of prostate-specific antigen (PSA) testing; it is only now tapering off. Screening for prostate cancer with PSA is widespread in the United States, yet controversial: the American Urological Association recommends PSA screening and the American Cancer Society recommends offering screening; however, the United States Preventive Services Task Force (USPSTF) and the American College of Physicians (ACP) recommend against routine screening; and the American Academy of Family Physicians believes that the decision to screen should be left to the patient.